A double-blind, randomised, parallel study comparing intravenous dolasetron plus dexamethasone and intravenous dolasetron alone for the management of fractionated cisplatin-related nausea and vomiting.

MLA

Fauser, A. A., et al. “A Double-Blind, Randomised, Parallel Study Comparing Intravenous Dolasetron plus Dexamethasone and Intravenous Dolasetron Alone for the Management of Fractionated Cisplatin-Related Nausea and Vomiting.” Supportive Care in Cancer, vol. 8, no. 1, Jan. 2000, pp. 49–54. EBSCOhost, https://doi.org/10.1007/s005209900090.

APA

Fauser, A. A., Pizzocaro, G., Schueller, J., Khayat, D., & Wilkinson, P. (2000). A double-blind, randomised, parallel study comparing intravenous dolasetron plus dexamethasone and intravenous dolasetron alone for the management of fractionated cisplatin-related nausea and vomiting. Supportive Care in Cancer, 8(1), 49–54. https://doi.org/10.1007/s005209900090

Chicago

Fauser, A. A., G. Pizzocaro, J. Schueller, D. Khayat, and P. Wilkinson. 2000. “A Double-Blind, Randomised, Parallel Study Comparing Intravenous Dolasetron plus Dexamethasone and Intravenous Dolasetron Alone for the Management of Fractionated Cisplatin-Related Nausea and Vomiting.” Supportive Care in Cancer 8 (1): 49–54. doi:10.1007/s005209900090.